BRAF NP_004324.2:p.V600M

Clinical trial pipeline · Data from ClinicalTrials.gov

See which BRAF NP_004324.2:p.V600M trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingPhase 2

NCT04061980

Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V…

This phase II trial studies how well encorafenib and binimetinib given with or without nivolumab works in treating patients with BRAF V600 mutation positive thy…

United States24 participantsStarted 2020-10-30

Treatment: Binimetinib, Encorafenib